Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262
NCT05740813Phase 3Completed
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fosigotifator in amyotrophic lateral sclerosis (ALS). Started Mar 2023; status: completed.
02
Drugs
fosigotifator
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT05740813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05740813.